As COVID-19 cases reduce, it seems pandemic-related stocks globally are seeing a correction. Vaccine manufacturers such as Moderna, Pfizer, BioNTech and Novavax have all corrected anywhere between 8 percent to over 20 percent just in the past one month.
The likes of Moderna have seen a steeper correction with the stock down 70 percent from its August 2021 highs.
Also Read:
While many of the companies have issue specific to the company – for example executives of Moderna, the manufacturer of the mRNA COVID-19 vaccine, have sold shares worth around USD 3.6 million last week – analysts have pegged the broader reason for the correction due to COVID-19 cases reducing and investors hence questioning if vaccines will be a sustainable revenue going forward.
Watch the accompanying video of CNBC-TV18’s Ekta Batra for more details.
Catch all stock market updates here
First Published: Feb 16, 2022 5:32 PM IST
Check out our in-depth Market Coverage, Business News & get real-time Stock Market Updates on CNBC-TV18. Also, Watch our channels CNBC-TV18, CNBC Awaaz and CNBC Bajar Live on-the-go!
Phase five Lok Sabha polls: Rae Bareli, Amethi among 14 UP seats going to polls on Monday
May 19, 2024 1:03 PM